share_log

Shockwave Medical Initiates All-Female Coronary Intravascular Lithotripsy Study To Treat Severely Calcified Cardiovascular Disease

Shockwave Medical Initiates All-Female Coronary Intravascular Lithotripsy Study To Treat Severely Calcified Cardiovascular Disease

衝擊波醫療公司啟動全女性冠狀動脈內碎石術治療嚴重鈣化心血管疾病的研究
Benzinga Real-time News ·  2022/09/19 09:06
EMPOWER CAD is the First Prospective, Female-Only Study of Coronary Interventions
Empower CAD是首個針對冠狀動脈介入治療的女性前瞻性研究
Study Seeks to Confirm Benefits of Shockwave's Coronary IVL in Females Who Historically Have Suffered Less Favorable Clinical Outcomes than Male Patients with Traditional Therapies
學習尋求確認Shockwave的冠狀動脈IVL對女性的好處從歷史上看,與使用傳統療法的男性患者相比,哪些患者的臨牀結果較差
SANTA CLARA, Calif., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, has initiated the first-ever prospective coronary intervention study consisting of all female patients – EMPOWER CAD – to determine whether the positive results from earlier coronary IVL studies with the Shockwave C2 Coronary IVL Catheter, which showed similar...
加利福尼亞州聖克拉拉,9月2022年10月19日(環球網)--開發血管內碎石術治療嚴重鈣化心血管疾病的先驅公司Shockwa...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論